Janus Henderson to acquire Rantum Capital to drive European private markets offering
Deal is set to close in Q3 2026; move will bolster the expansion of the asset manager’s private credit platform across the Continent.
Deal is set to close in Q3 2026; move will bolster the expansion of the asset manager’s private credit platform across the Continent.
The offering will allow institutional investors to estimate counterparty price commitment prior to indicating intent to trade; T.Rowe Price has signed on as an anchor client, The TRADE understands.
The collaboration expands the two firm’s ongoing partnership and will allow Marathon to home in on greater client service engagement and investment decisions.
Following the completion of the transaction, Corient's offering now spans more than 300 partners and an excess of $500 billion for its client base.
Rising Stars will be recognised as part of a standalone event on 30 September, in collaboration with Instinet; nominations can be made for any candidate currently working in a trading role within a buy-side firm.
The past week has seen several significant moves, including a head of electronic trading departure, and senior buy-side hires across ETF capital markets and quantitative trading.
The trade, enabled through Bloomberg Tradebook, expands buy-side access to bank and market maker liquidity for options and futures and allows investors to leverage off-book liquidity fully electronically, The TRADE understands.
Ahead of The TRADE’s upcoming results of its Algorithmic Trading Survey: Hedge Funds 2026, Natasha Cocksedge reflects on the findings from 2025, analysing how algorithmic trading has cemented its spot at the core of hedge fund execution, and how this trend might continue over the coming year.
The move marks a return to the buy-side firm for new hire, who previously spent five years at State Street Investment Management in various senior ETF-related roles.
New hire joins the investment manager from 1 June, and also previously served at firms including IMC Trading, Exane and Societe Generale.